Hydrogels are among the most widely studied biomaterials in modern drug delivery research. Their high hydrophilicity, ...

Nanoparticle-based drug delivery systems utilise the unique physicochemical properties of nanoscale carriers to enhance therapeutic efficacy whilst minimising systemic side effects. These formulations ...

Scientists engaged in precision medicine research focus intensely on target-based drug development. In doing so, they help improve the safety and efficacy profiles of future therapies by reducing ...

DDS can be based on physical mechanisms like osmosis, diffusion, erosion, dissolution, and electro-transport or biochemical methods like monoclonal antibodies, gene therapy, vector systems, ...

Dr. Yu Zheng, together with her graduate student Qin Qin (from the Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University), developed ...

Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer ...

A couple of University of Nebraska professors have launched a startup company with the goal of bringing to market an innovative method for delivering drugs and other therapeutics to targeted locations ...

Polyrizon Ltd., a biotechnology company focused on intranasal drug delivery systems, has reported promising preclinical results for its hydrogel-based Trap & Target (T&T) platform, developed in ...

How do you send drugs to specific parts of the body so they do their job and avoid causing side effects elsewhere? According to researchers at Stanford University, the answer is a combination of ...

Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer ...

Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer ...